Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.

van Wier MF, Lakerveld J, Bot SD, Chinapaw MJ, Nijpels G, van Tulder MW.

BMC Fam Pract. 2013 Apr 4;14:45. doi: 10.1186/1471-2296-14-45.

2.

A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.

Campbell F, Holmes M, Everson-Hock E, Davis S, Buckley Woods H, Anokye N, Tappenden P, Kaltenthaler E.

Health Technol Assess. 2015 Jul;19(60):1-110. doi: 10.3310/hta19600. Review.

3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

5.

Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, Hopkins D, Pronk NP.

Ann Intern Med. 2015 Sep 15;163(6):452-60. doi: 10.7326/M15-0469. Review.

6.

Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review.

Singh K, Chandra Sekaran AM, Bhaumik S, Aisola M, Chattopadhyay K, Gamage AU, de Silva P, Selvaraj S, Roy A, Prabhakaran D, Tandon N.

BMJ Open. 2015 Mar 10;5(3):e007205. doi: 10.1136/bmjopen-2014-007205. Review.

7.

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Johnston CA, Moreno JP, Foreyt JP.

Curr Atheroscler Rep. 2014 Dec;16(12):457. doi: 10.1007/s11883-014-0457-6. Review.

8.

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.

Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C.

BMC Public Health. 2015 Nov 26;15:1183. doi: 10.1186/s12889-015-2538-z. Review.

9.

Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Saha S, Gerdtham UG, Johansson P.

Int J Environ Res Public Health. 2010 Aug;7(8):3150-95. doi: 10.3390/ijerph7083150. Epub 2010 Aug 9. Review.

10.

Prevention of type 2 diabetes and its complications in developing countries: a review.

Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B.

Int J Behav Med. 2012 Jun;19(2):121-33. doi: 10.1007/s12529-011-9162-9. Review.

11.

Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies.

Alouki K, Delisle H, Bermúdez-Tamayo C, Johri M.

J Diabetes Res. 2016;2016:2159890. doi: 10.1155/2016/2159890. Epub 2016 Jan 13. Review.

Supplemental Content

Support Center